SCHEMBL16812612

SCHEMBL16812612

Cc1c(C(=O)NC2CCN(Cc3ccc(N4CCC(NC(=O)c5cccc(-c6cccnc6)c5)CC4)nc3)CC2)cccc1-c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 3/20 0.70
▸ SSTR5 P35346 3/20 0.48
▸ DRD4 P21917 3/20 0.48
▸ HTR2A P28223 2/20 0.48
▸ DRD2 P14416 1/20 0.48
▸ SLC6A5 Q9Y345 1/20 0.47
▸ PGR P06401 1/20 0.47
▸ GPR183 P32249 1/20 0.47
▸ RET P07949 1/20 0.43
▸ ABL1 P00519 3/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ PRKAA2 P54646 3/20 0.42
▸ PRKAB2 O43741 1/20 0.42
▸ PRKAG1 P54619 1/20 0.42
▸ PRKAA1 Q13131 1/20 0.42
▸ PRKAG3 Q9UGI9 1/20 0.42
▸ PRKAG2 Q9UGJ0 1/20 0.42
▸ PRKAB1 Q9Y478 1/20 0.42
▸ SCN5A Q14524 1/20 0.42
▸ SCN9A Q15858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16812576 0.93 SMO (0.69) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16812611 0.93 SMO (0.71) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16812613 0.93 SMO (0.70) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16811859 0.92 SMO (0.84) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16811873 0.92 SMO (0.84) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16812623 0.91 SMO (0.72) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16811994 0.91 SMO (0.78) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16812013 0.90 SMO (0.79) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL16811981 0.90 SMO (0.79) SMOSSTR5DRD4HTR2ADRD2
SCHEMBL18286601 0.90 SMO (0.53) SMOSSTR5DRD4HTR2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885SSTR5 1894/4885DRD4 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback